Genomic evidence supports a clonal diaspora model for metastases of esophageal adenocarcinoma
暂无分享,去创建一个
M. Stratton | A. Hindmarsh | D. Wedge | I. Martincorena | L. Alexandrov | S. D. Preston | R. Hardwick | R. Fitzgerald | A. Noorani | M. Goddard | M. Eldridge | P. Lao-Sirieix | A. Miremadi | Xiaodun Li | L. Bower | N. Grehan | S. Macrae | M. Secrier | J. Weaver | S. Malhotra | D. Gilligan | J. Crawte | S. Galbraith | Tabitha Thomas | I. Debiram-Beecham | Lorraine Petersen | Lawrence Bower
[1] Michael C. Ryan,et al. for single-cell sequencing data , 2020 .
[2] Jeffrey W. Clark,et al. Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers , 2019, Nature Medicine.
[3] C. Curtis,et al. Quantitative evidence for early metastatic seeding in colorectal cancer , 2019, Nature Genetics.
[4] Yuan Ji,et al. Portraits of genetic intra-tumour heterogeneity and subclonal selection across cancer types , 2018, bioRxiv.
[5] S. Tavaré,et al. The landscape of selection in 551 esophageal adenocarcinomas defines genomic biomarkers for the clinic , 2018, bioRxiv.
[6] Peter J. Park,et al. Aging and neurodegeneration are associated with increased mutations in single human neurons , 2017, Science.
[7] Nicola D. Roberts,et al. Pan-cancer analysis of whole genomes reveals driver rearrangements promoted by LINE-1 retrotransposition in human tumours , 2017, bioRxiv.
[8] Benjamin J. Raphael,et al. The evolutionary history of 2,658 cancers , 2017, Nature.
[9] G. Getz,et al. Mutational patterns in chemotherapy resistant muscle-invasive bladder cancer , 2017, Nature Communications.
[10] Jesper Lagergren,et al. Oesophageal cancer , 2017, The Lancet.
[11] Chuang Tan,et al. Universal Patterns of Selection in Cancer and Somatic Tissues , 2018, Cell.
[12] S. Imbeaud,et al. Mutational signatures reveal the dynamic interplay of risk factors and cellular processes during liver tumorigenesis , 2017, Nature Communications.
[13] Jack Kuipers,et al. Single-cell sequencing data reveal widespread recurrence and loss of mutational hits in the life histories of tumors , 2017, Genome research.
[14] D. Sugarbaker,et al. Utility of Adjuvant Chemotherapy After Neoadjuvant Chemoradiation and Esophagectomy for Esophageal Cancer , 2017, Annals of surgery.
[15] L. Dizdar,et al. Disseminated tumour cells with highly aberrant genomes are linked to poor prognosis in operable oesophageal adenocarcinoma , 2017, British Journal of Cancer.
[16] Tom Sante,et al. Shallow Whole Genome Sequencing on Circulating Cell-Free DNA Allows Reliable Noninvasive Copy-Number Profiling in Neuroblastoma Patients , 2017, Clinical Cancer Research.
[17] Johannes G. Reiter,et al. Origins of lymphatic and distant metastases in human colorectal cancer , 2017, Science.
[18] Y. Kitagawa,et al. Three-field lymph node dissection in esophageal cancer surgery. , 2017, Journal of thoracic disease.
[19] Robert J. Lonigro,et al. Integrative Clinical Genomics of Metastatic Cancer , 2017, Nature.
[20] S. Hochwald,et al. Novel Calculator to Estimate Overall Survival Benefit from Neoadjuvant Chemoradiation in Patients with Esophageal Adenocarcinoma. , 2017, Journal of the American College of Surgeons.
[21] M. Stratton,et al. Universal Patterns of Selection in Cancer and Somatic Tissues , 2017, bioRxiv.
[22] Nicholas Navin,et al. Tumor evolution: Linear, branching, neutral or punctuated? , 2017, Biochimica et biophysica acta. Reviews on cancer.
[23] S. Mocellin,et al. Survival After Neoadjuvant and Adjuvant Treatments Compared to Surgery Alone for Resectable Esophageal Carcinoma: A Network Meta-analysis , 2017, Annals of surgery.
[24] M. Shah,et al. Oesophageal cancer , 2017, Nature Reviews Disease Primers.
[25] Hans Clevers,et al. Tissue-specific mutation accumulation in human adult stem cells during life , 2016, Nature.
[26] Christophe Badie,et al. Mutational signatures of ionizing radiation in second malignancies , 2016, Nature Communications.
[27] Simon Tavaré,et al. Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance , 2016, Nature Genetics.
[28] Xiaoyu Chen,et al. Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications , 2016, Bioinform..
[29] G. Sella,et al. Interpreting the Dependence of Mutation Rates on Age and Time , 2015, PLoS biology.
[30] M. Stratton,et al. Clock-like mutational processes in human somatic cells , 2015, Nature Genetics.
[31] Ole Schulz-Trieglaff,et al. Manta: Rapid detection of structural variants and indels for clinical sequencing applications , 2015, bioRxiv.
[32] S. Tavaré,et al. Whole-genome sequencing provides new insights into the clonal architecture of Barrett’s esophagus and esophageal adenocarcinoma , 2015, Nature Genetics.
[33] Andrew Menzies,et al. Subclonal diversification of primary breast cancer revealed by multiregion sequencing , 2015, Nature Medicine.
[34] Nicolai J. Birkbak,et al. Tracking the genomic evolution of esophageal adenocarcinoma through neoadjuvant chemotherapy. , 2015, Cancer discovery.
[35] M. Nykter,et al. The Evolutionary History of Lethal Metastatic Prostate Cancer , 2015, Nature.
[36] C. Curtis,et al. A Big Bang model of human colorectal tumor growth , 2015, Nature Genetics.
[37] Quan P. Ly,et al. Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. , 2019, Journal of the National Comprehensive Cancer Network : JNCCN.
[38] Pieter Wesseling,et al. DNA copy number analysis of fresh and formalin-fixed specimens by shallow whole-genome sequencing with identification and exclusion of problematic regions in the genome assembly , 2014, Genome research.
[39] Peter J. Campbell,et al. Genomic catastrophes frequently arise in esophageal adenocarcinoma and drive tumorigenesis , 2014, Nature Communications.
[40] Rebecca C Fitzgerald,et al. Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis , 2014, Nature Genetics.
[41] G. Parmigiani,et al. Heterogeneity of genomic evolution and mutational profiles in multiple myeloma , 2014, Nature Communications.
[42] C. Sima,et al. Esophageal Cancer Recurrence Patterns and Implications for Surveillance , 2013, Journal of Thoracic Oncology.
[43] David T. W. Jones,et al. Signatures of mutational processes in human cancer , 2013, Nature.
[44] Bruce A. Robertson,et al. The Cancer Diaspora: Metastasis beyond the seed and soil hypothesis , 2013, 1308.1938.
[45] A. McKenna,et al. Exome and whole genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity , 2013, Nature Genetics.
[46] V. P. Collins,et al. Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics , 2013, Proceedings of the National Academy of Sciences.
[47] Shankar Vembu,et al. Inferring clonal evolution of tumors from single nucleotide somatic mutations , 2012, BMC Bioinformatics.
[48] Kenny Q. Ye,et al. An integrated map of genetic variation from 1,092 human genomes , 2012, Nature.
[49] Peter J. Campbell,et al. Evolution of the cancer genome , 2012, Nature Reviews Genetics.
[50] N. Altorki,et al. Worldwide Oesophageal Cancer Collaboration guidelines for lymphadenectomy predict survival following neoadjuvant therapy. , 2012, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[51] M. Meyerson,et al. Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis. , 2012, Cancer research.
[52] A. Børresen-Dale,et al. The Life History of 21 Breast Cancers , 2012, Cell.
[53] Wendy S. W. Wong,et al. Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs , 2012, Bioinform..
[54] O. Yokosuka,et al. Abstract 4383: Targeting tumor microenvironment with gemcitabine is useful for the treatment of pancreatic ductal adenocarcinoma , 2012 .
[55] Carlo C. Maley,et al. Clonal evolution in cancer , 2012, Nature.
[56] C. Compton,et al. Esophagus and Esophagogastric Junction , 2012 .
[57] V. Gebski,et al. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. , 2011, The Lancet. Oncology.
[58] 闵先军,et al. Oesophageal cancer , 2011 .
[59] Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition , 2011, Gastric Cancer.
[60] M. Nowak,et al. Distant Metastasis Occurs Late during the Genetic Evolution of Pancreatic Cancer , 2010, Nature.
[61] Pauline C Ng,et al. Whole genome sequencing. , 2010, Methods in molecular biology.
[62] Larry Norton,et al. Tumor Self-Seeding by Circulating Cancer Cells , 2009, Cell.
[63] Richard Durbin,et al. Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .
[64] C. Klein,et al. Parallel progression of primary tumours and metastases , 2009, Nature Reviews Cancer.
[65] A. Ullrich,et al. Direct genetic analysis of single disseminated cancer cells for prediction of outcome and therapy selection in esophageal cancer. , 2008, Cancer cell.
[66] W. Budach,et al. Capecitabine and oxaliplatin for advanced esophagogastric cancer. , 2008, The New England journal of medicine.
[67] Clive R. Taylor,et al. The prognostic importance of immunohistochemically detected node metastases in resected esophageal adenocarcinoma. , 2004, The Annals of thoracic surgery.
[68] C. Mariette,et al. Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease , 2003, Cancer.
[69] H. Kalthoff,et al. Disseminated tumour cells , 2001, Virchows Archiv.
[70] M. Sporn. The war on cancer , 1996, The Lancet.
[71] 胃癌研究会. Japanese classification of gastric carcinoma , 1995 .
[72] P. Nowell. The clonal evolution of tumor cell populations. , 1976, Science.
[73] L. Foulds. The experimental study of tumor progression: a review. , 1954, Cancer research.
[74] Anita D. Laton,et al. A life history , 1943 .